Cited by 2,137Gut microbiota and healthAlzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.

Gut microbiome alterations in Alzheimer’s disease

Open access

Vogt, Nicholas M., Kerby, Robert L., Dill-McFarland, Kimberly A., Harding, Sandra J., Merluzzi, Andrew P., Johnson, Sterling C., Carlsson, Cynthia M., Asthana, Sanjay, Zetterberg, Henrik, Blennow, Kaj, Bendlin, Barbara B., Rey, Federico E.·2017·Scientific Reports

DOI 10.1038/s41598-017-13601-yPMC PMC5648830

Open this paper in CoChat — free account Open PDF

Abstract

Alzheimer’s disease (AD) is the most common form of dementia. However, the etiopathogenesis of this devastating disease is not fully understood. Recent studies in rodents suggest that alterations in the gut microbiome may contribute to amyloid deposition, yet the microbial communities associated with AD have not been characterized in humans. Towards this end, we characterized the bacterial taxonomic composition of fecal samples from participants with and without a diagnosis of dementia due to AD. Our analyses revealed that the gut microbiome of AD participants has decreased microbial diversity and is compositionally distinct from control age- and sex-matched individuals. We identified phylum- through genus-wide differences in bacterial abundance including decreased Firmicutes, increased Bacteroidetes, and decreased Bifidobacterium in the microbiome of AD participants. Furthermore, we observed correlations between levels of differentially abundant genera and cerebrospinal fluid (CSF) biomarkers of AD. These findings add AD to the growing list of diseases associated with gut microbial alterations, as well as suggest that gut bacterial communities may be a target for therapeutic intervention.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41598-017-13601-y

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Figure 1 Alzheimer’s disease is associated with alterations in gut microbiome composition. (A) Faith’s Phylogenetic Diversity is decreased in the microbiome of AD participants. *p < 0.05. (B) Non-metric multidimensional scaling (NMDS) plot of weighted UniFrac analysis of relative sample OTU composition. NMDS analysis was limited to two dimensions, with a stress measurement of 0.17. Each dot represents a scaled measure of the composition of a given participant, color- and shape-coded by cohort. (C) Differential abundance analysis identified 14 OTUs that were increased and 68 OTUs that were decreased in AD relative to Control participants (p < 0.05, FDR-corrected). Each point represents an OTU. Data plotted as log2 fold change; OTUs to the right of the zero line are more abundant and OTUs to the left of the zero line are less abundant in AD compared to Control groups. OTUs are organized on the y-axis according to the lowest taxonomic classification possible. (D) OTUs grouped at the phylum level and analyzed using Metastats show that AD participants have decreased abundance of Firmicutes and Actinobacteria, and increased abundance of Bacteroidetes compared to Control participants (p < 0.05, FDR-corrected). Tukey plots show median, IQR, and participant data points for phylum relative abundance.CC BY · PubMed Central

Figure 2 Bacterial families and genera differentially represented in feces from AD participants compared to Control participants (p < 0.05, FDR-corrected). Tukey plots are colored by phylum and show median, IQR, and participant data points for genus or family relative abundance.CC BY · PubMed Central

Figure 3 Bacterial taxa correlate with CSF biomarkers of AD pathology. 13 genera identified as differentially abundant in AD were correlated with CSF biomarkers of AD including the Aβ42/Aβ40 ratio (with lower CSF levels reflecting greater amyloid deposition in the brain), phosphorylated tau (p-tau), and the p-tau/Aβ42 ratio (which incorporates both facets of AD pathology). Correlations were calculated separately for all 40 participants (All), 31 non-demented participants (ND), and 9 AD participants (AD). In general, genera identified as more abundant in AD were associated with greater AD pathology, while genera identified as less abundant in AD were associated with less AD pathology. Genera are ordered from most to least abundant. Shape and color of ellipses represent strength of Spearman’s rank correlation coefficients (rho). Bolded ellipse borders represent significant correlations (two-sided, p < 0.05 uncorrected).CC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences
Langille, M. G. I., Zaneveld, J., Caporaso, J. G., McDonald, D., Knights, D., Reyes, J. A., Clemente, J. C., Burkepile, D. E., Vega Thurber, R. L., Knight, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2676 · Cited by 9,116
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Development of a Dual-Index Sequencing Strategy and Curation Pipeline for Analyzing Amplicon Sequence Data on the MiSeq Illumina Sequencing Platform
Kozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K., & Schloss, P. D. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.01043-13 · Cited by 7,246
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176

Show all 83 references

Sorted by citations

Items 401–500 of 1,007

Association between Gut Microbiota with Mild Cognitive Impairment and Alzheimer’s Disease in a Thai Population
Wanapaisan, P., Chuansangeam, M., Nopnipa, S., Mathuranyanon, R., Nonthabenjawan, N., Ngamsombat, C., Thientunyakit, T., & Muangpaisan, W. (2022) · Neurodegenerative Diseases · doi:10.1159/000526947 · Cited by 67
The Antioxidant Effect of Dietary Bioactives Arises from the Interplay between the Physiology of the Host and the Gut Microbiota: Involvement of Short-Chain Fatty Acids
Cuciniello, R., Meo, F. D., Filosa, S., Crispi, S., & Bergamo, P. (2023) · Antioxidants · doi:10.3390/antiox12051073 · Cited by 69
Alzheimer's disease and symbiotic microbiota: an evolutionary medicine perspective
Fox, M. M., Knorr, D. A., & Haptonstall, K. P. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14129 · Cited by 67
Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer’s Disease
Atlante, A., Amadoro, G., Bobba, A., & Latina, V. (2020) · Cells · doi:10.3390/cells9112347 · Cited by 67
Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer’s Disease
Nagu, P., Parashar, A., Behl, T., & Mehta, V. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01829-3 · Cited by 68
The Role of the Gut Microbiome in Diet and Exercise Effects on Cognition: A Review of the Intervention Literature
Koblinsky, N. D., Power, K. A., Middleton, L. E., Ferland, G., & Anderson, N. D. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac166 · Cited by 66
Taming neuroinflammation in Alzheimer's disease: The protective role of phytochemicals through the gut−brain axis
Kim, Y., Lim, J., & Oh, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117277 · Cited by 67
Microbiome-derived indole-3-lactic acid reduces amyloidopathy through aryl-hydrocarbon receptor activation
Kim, H., Lee, E., Park, M. K., Min, K., Diep, Y. N., Kim, J., Ahn, H., Lee, E., Kim, S., Kim, Y., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.08.051 · Cited by 66
Good Bug, Bad Bug: Breaking through Microbial Stereotypes
Cirstea, M. S., Radisavljevic, N., & Finlay, B. B. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2017.12.008 · Cited by 66
Systems Biology Approaches to Understand the Host–Microbiome Interactions in Neurodegenerative Diseases
Rosário, D., Borén, J., Uhlén, M., Proctor, G., Aarsland, D., Mardinoğlu, A., & Shoaie, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00716 · Cited by 66
Prebiotic effects of yeast mannan, which selectively promotes Bacteroides thetaiotaomicron and Bacteroides ovatus in a human colonic microbiota model
Oba, S., Sunagawa, T., Tanihiro, R., Awashima, K., Sugiyama, H., Odani, T., Nakamura, Y., Kondo, A., Sasaki, D., & Sasaki, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-74379-0 · Cited by 66
Gut microbiota and epilepsy: a systematic review on their relationship and possible therapeutics
Arulsamy, A., Tan, Q. Y., Balasubramaniam, V., O’Brien, T. J., & Shaikh, M. F. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00431 · Cited by 65
Improving causality in microbiome research: can human genetic epidemiology help?
Wade, K. H., & Hall, L. J. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15628.3 · Cited by 65
Sesamol Attenuates Amyloid Peptide Accumulation and Cognitive Deficits in APP/PS1 Mice: The Mediating Role of the Gut–Brain Axis
Liu, Q. F., Xie, T., Xi, Y., Li, L., Mo, F., Liu, X., Liu, Z., Gao, J., & Yuan, T. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c04687 · Cited by 66
Effects of Traumatic Brain Injury on the Gut Microbiota Composition and Serum Amino Acid Profile in Rats
Taraskina, A. N., Ignatyeva, O. A., Lisovaya, D., Ivanov, M., Ivanova, L. G., Golovicheva, V., Baydakova, G., Silachev, D. N., Popkov, V. A., Ivanets, T. Y., et al. (2022) · Cells · doi:10.3390/cells11091409 · Cited by 66
What Are the Key Gut Microbiota Involved in Neurological Diseases? A Systematic Review
Bonnechère, B., Amin, N., & van Duijn, C. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213665 · Cited by 68
Gut microbiota changes in patients with Alzheimer’s disease spectrum based on 16S rRNA sequencing: a systematic review and meta-analysis
Li, H., Cui, X., Lin, Y., Huang, F., Tian, A., & Zhang, R. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1422350 · Cited by 65
Reproductive Senescence and Ischemic Stroke Remodel the Gut Microbiome and Modulate the Effects of Estrogen Treatment in Female Rats
Park, M. J., Pilla, R., Panta, A., Pandey, S., Sarawichitr, B., Suchodolski, J. S., & Sohrabji, F. (2019) · Translational Stroke Research · doi:10.1007/s12975-019-00760-5 · Cited by 65
Periodontal Disease and Periodontal Disease-Related Bacteria Involved in the Pathogenesis of Alzheimer’s Disease
Matsushita, K., Yamada-Furukawa, M., Kurosawa, M., & Shikama, Y. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s255309 · Cited by 64
Human Gut Microbiota Plasticity throughout the Life Course
Thriene, K., & Michels, K. B. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20021463 · Cited by 65
Berberine alleviates Alzheimer's disease by regulating the gut microenvironment, restoring the gut barrier and brain-gut axis balance
Sun, C., Dong, S., Chen, W., Li, S., Luo, E., & Ji, J. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155624 · Cited by 64
The microbiota-gut-brain-immune interface in the pathogenesis of neuroinflammatory diseases: a narrative review of the emerging literature
Warren, A., Nyavor, Y., Zarabian, N., Mahoney, A., & Frame, L. A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1365673 · Cited by 64
Protection of Alzheimer’s disease progression by a human-origin probiotics cocktail
Prajapati, S. K., Wang, S., Mishra, S. P., Jain, S., & Yadav, H. (2025) · Scientific Reports · doi:10.1038/s41598-024-84780-8 · Cited by 64
Synergistic effects of APOE and sex on the gut microbiome of young EFAD transgenic mice
Weng, J. M., Parikh, I. J., Naqib, A. D., York, J. M., Green, S. J., Estus, S., & LaDu, M. J. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0352-2 · Cited by 65
The Microbiota–Gut–Brain Axis and Alzheimer Disease. From Dysbiosis to Neurodegeneration: Focus on the Central Nervous System Glial Cells
Giovannini, M. G., Lana, D., Traini, C., & Vannucchi, M. G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112358 · Cited by 64
Can We Treat Neuroinflammation in Alzheimer’s Disease?
Sánchez‐Sarasúa, S., Fernández-Pérez, I., Espinosa‐Fernández, V., Sánchez‐Pérez, A. M., & Ledesma, J. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228751 · Cited by 64
Gut microbiome alterations in preclinical Alzheimer’s disease
Jung, J. H., Kim, G., Byun, M. S., Lee, J. H., Yi, D., Park, H., & Lee, D. Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278276 · Cited by 63
Gut microbiome predicts cognitive function and depressive symptoms in late life
Kolobaric, A., Andreescu, C., Jašarević, E., Hong, C. H., Roh, H., Cheong, J. Y., Kim, Y., Shin, T. S., Kang, C. S., Kwon, C. O., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02551-3 · Cited by 63
Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome?
Newberry, F., Hsieh, S.-Y., Wileman, T., & Carding, S. R. (2018) · Clinical Science · doi:10.1042/cs20171330 · Cited by 63
The Impact of Chronic Intestinal Inflammation on Brain Disorders: the Microbiota-Gut-Brain Axis
Serra, D., Almeida, L. M., & Dinis, T. C. P. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1572-8 · Cited by 63
Gut microbiome: An intermediary to neurotoxicity
Dempsey, J. L., Little, M., & Cui, J. Y. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.08.005 · Cited by 63
Profiling the oral microbiomes in patients with Alzheimer's disease
Guo, H., Li, B., Yao, H., Liu, D., Chen, R., Zhou, S., Ji, Y., Zeng, L., & Du, M. (2021) · Oral Diseases · doi:10.1111/odi.14110 · Cited by 62
Stratification of the Gut Microbiota Composition Landscape across the Alzheimer's Disease Continuum in a Turkish Cohort
Yıldırım, S., Nalbantoğlu, Ö. U., Bayraktar, A., Ercan, F. B., Gündoğdu, A., Velioğlu, H. A., Göl, M. F., Ekinci, A., Koç, F., Aslan-Gülpınar, E., et al. (2022) · mSystems · doi:10.1128/msystems.00004-22 · Cited by 62
Neuroprotective effects of polysaccharide from Sparassis crispa on Alzheimer's disease-like mice: Involvement of microbiota-gut-brain axis
Zhang, W., Guo, Y., Cheng, Y., Yao, W., & Qian, H. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.11.160 · Cited by 62
The potential of human milk oligosaccharides to impact the microbiota-gut-brain axis through modulation of the gut microbiota
Al-Khafaji, A. H., Jepsen, S. D., Christensen, K. R., & Vigsnæs, L. K. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104176 · Cited by 62
Gut Microbiota Alterations and Cognitive Impairment Are Sexually Dissociated in a Transgenic Mice Model of Alzheimer’s Disease
Cuervo-Zanatta, D., Garcı́a-Mena, J., & Perez‐Cruz, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201367 · Cited by 62
Dietary Regulation of Gut-Brain Axis in Alzheimer’s Disease: Importance of Microbiota Metabolites
Frausto, D. M., Forsyth, C. B., Keshavarzian, A., & Voigt, R. M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.736814 · Cited by 61
A review on preventive role of ketogenic diet (KD) in CNS disorders from the gut microbiota perspective
Rawat, K., Singh, N., Kumari, P., & Saha, L. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0078 · Cited by 61
Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders
Gupta, R. V., Advani, D., Yadav, D., Ambasta, R. K., & Kumar, P. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03502-9 · Cited by 61
The contribution of age-related changes in the gut-brain axis to neurological disorders
Khan, R., Gesù, C. M. D., Lee, J., & McCullough, L. D. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2302801 · Cited by 62
Understanding the impact of age-related changes in the gut microbiome on chronic diseases and the prospect of elderly-specific dietary interventions
Pellanda, P., Ghosh, T. S., & O’Toole, P. W. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.11.001 · Cited by 60
Increasing breast milk betaine modulates Akkermansia abundance in mammalian neonates and improves long-term metabolic health
Ribó, S., Sánchez‐Infantes, D., Martínez-Guinó, L., García‐Mantrana, I., Ramon‐Krauel, M., Tondo, M., Arning, E., Nofrarías, M., Osorio-Conles, Ó., Fernández-Pérez, A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb0322 · Cited by 60
The Gut Microbiome–Brain Crosstalk in Neurodegenerative Diseases
Ghezzi, L., Cantoni, C., Rotondo, E., & Galimberti, D. (2022) · Biomedicines · doi:10.3390/biomedicines10071486 · Cited by 61
Gut microbiota and intestinal barrier function in subjects with cognitive impairments: a cross-sectional study
Pei, Y., Yan, L., Li, H., Jiang, C., & Wang, L. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1174599 · Cited by 60
Lactobacillus plantarum PS128 ameliorates 2,5-Dimethoxy-4-iodoamphetamine-induced tic-like behaviors via its influences on the microbiota–gut-brain-axis
Liao, J.-F., Cheng, Y.-F., Li, S.-W., Lee, W., Hsu, C.-C., Wu, C.-C., Jeng, O.-J., Wang, S. Z., & Tsai, Y.-C. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.07.027 · Cited by 60
Longitudinal Analysis of the Microbiome and Metabolome in the 5xfAD Mouse Model of Alzheimer’s Disease
Dunham, S. J. B., McNair, K., Adams, E. D., Avelar‐Barragan, J., Forner, S., Mapstone, M. E., & Whiteson, K. (2022) · mBio · doi:10.1128/mbio.01794-22 · Cited by 59
Gut microbiota in dementia with Lewy bodies
Nishiwaki, H., Ueyama, J., Kashihara, K., Ito, M., Hamaguchi, T., Maeda, T., Tsuboi, Y., Katsuno, M., Hirayama, M., & Ohno, K. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00428-2 · Cited by 59
Gut Microbiota and Alzheimer’s Disease: How to Study and Apply Their Relationship
Nguyen, N. M., Cho, J., & Lee, C.-H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044047 · Cited by 60
Physical Exercise as Disease-Modifying Alternative against Alzheimer’s Disease: A Gut–Muscle–Brain Partnership
Cutuli, D., Decandia, D., Giacovazzo, G., & Coccurello, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914686 · Cited by 61
A review on the use of prebiotics in ulcerative colitis
Kennedy, J. M., Silva, A. D., Walton, G., & Gibson, G. R. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.11.007 · Cited by 60
The gut microbiome regulates astrocyte reaction to Aβ amyloidosis through microglial dependent and independent mechanisms
Chandra, S., Di Meco, A., Dodiya, H. B., Popovic, J., Cuddy, L. K., Weigle, I. Q., Zhang, X., Sadleir, K., Sisodia, S. S., & Vassar, R. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00635-2 · Cited by 58
The Role of the Microbiota-Gut-Brain Axis in the Development of Alzheimer’s Disease
Wiatrak, B., Balon, K., Jawień, P., Bednarz, D., Jęśkowiak, I., & Szeląg, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094862 · Cited by 58
Polyphenols, the new frontiers of prebiotics
Nazzaro, F., Fratianni, F., Feo, V. D., Battistelli, A., da Cruz, A. G., & Coppola, R. (2020) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2020.06.002 · Cited by 58
Gut microbiome alpha-diversity is not a marker of Parkinson’s disease and multiple sclerosis
Plassais, J., Gbikpi‐Benissan, G., Figarol, M., Scheperjans, F., Gorochov, G., Derkinderen, P., & Cervino, A. (2021) · Brain Communications · doi:10.1093/braincomms/fcab113 · Cited by 58
Microbiota-gut-brain axis and Alzheimer’s disease: Implications of the blood-brain barrier as an intervention target
Liu, S., Gao, J., Liu, K., & Zhang, H. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111560 · Cited by 59
Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation
Cheon, S. Y., & Song, J. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00836-0 · Cited by 58
Novelties on Neuroinflammation in Alzheimer’s Disease–Focus on Gut and Oral Microbiota Involvement
Popescu, C., Munteanu, C., Anghelescu, A., Ciobanu, V., Spînu, A., Andone, I., Mandu, M., Bistriceanu, R., Băilă, M., Postoiu, R.-L., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011272 · Cited by 61
The gut microbiome, immune modulation, and cognitive decline: insights on the gut-brain axis
Zhang, R., Ding, N., Feng, X., & Liao, W. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1529958 · Cited by 61
Differences in Gut Microbiota Profiles between Autoimmune Pancreatitis and Chronic Pancreatitis
Hamada, S., Masamune, A., Nabeshima, T., & Shimosegawa, T. (2018) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.244.113 · Cited by 58
Human Gut-Microbiota Interaction in Neurodegenerative Disorders and Current Engineered Tools for Its Modeling
Ceppa, F., Izzo, L., Sardelli, L., Raimondi, I., Tunesi, M., Albani, D., & Giordano, C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00297 · Cited by 58
Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and Neurodegeneration
Gentile, F., Doneddu, P. E., Riva, N., Nobile‐Orazio, E., & Quattrini, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207471 · Cited by 58
Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer’s Disease
Zhu, F., Li, C., Chu, F., Tian, X., & Zhu, J. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.544235 · Cited by 59
The gut microbiota is an emerging target for improving brain health during ageing
Boehme, M., Guzzetta, K. E., Wasén, C., & Cox, L. M. (2022) · Gut Microbiome · doi:10.1017/gmb.2022.11 · Cited by 57
Melatonin as a Mediator of the Gut Microbiota–Host Interaction: Implications for Health and Disease
Bonmatí‐Carrión, M., & Rol, M. A. (2023) · Antioxidants · doi:10.3390/antiox13010034 · Cited by 57
Time‐restricted feeding mitigates Alzheimer's disease‐associated cognitive impairments via a B. pseudolongum ‐propionic acid‐FFAR3 axis
Zhao, Y., Jia, M., Ding, C., Bao, B., Li, H., Ma, J., Dong, W., Gao, R., Chen, X., Chen, J., et al. (2025) · iMeta · doi:10.1002/imt2.70006 · Cited by 57
Alterations in gut bacterial and fungal microbiomes are associated with bacterial Keratitis, an inflammatory disease of the human eye
Jayasudha, R., Chakravarthy, S. K., Prashanthi, G. S., Sharma, S., Garg, P., Murthy, S. I., & Shivaji, S. (2018) · Journal of Biosciences · doi:10.1007/s12038-018-9798-6 · Cited by 57
Evidences for a Role of Gut Microbiota in Pathogenesis and Management of Epilepsy
Amlerová, J., Šroubek, J., Angelucci, F., & Hort, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115576 · Cited by 57
Surgical Menopause and Estrogen Therapy Modulate the Gut Microbiota, Obesity Markers, and Spatial Memory in Rats
Zeibich, L., Koebele, S. V., Bernaud, V. E., Ilhan, Z. E., Dirks, B., Northup-Smith, S. N., Neeley, R., Maldonado, J., Nirmalkar, K., Files, J. A., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.702628 · Cited by 57
Nutrition, gut microbiota, and alzheimer’s disease
Romanenko, M., Kholin, V., Koliada, A., & Vaiserman, A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.712673 · Cited by 56
The microbiome: A target for Alzheimer disease?
Seo, D.-O., Boros, B. D., & Holtzman, D. M. (2019) · Cell Research · doi:10.1038/s41422-019-0227-7 · Cited by 56
Vitamin K2 Holds Promise for Alzheimer’s Prevention and Treatment
Popescu, A., & German, M. (2021) · Nutrients · doi:10.3390/nu13072206 · Cited by 57
Alleviation effects of grape seed proanthocyanidin extract on inflammation and oxidative stress in a d -galactose-induced aging mouse model by modulating the gut microbiota
Sheng, K., Yang, J., Xu, Y., Kong, X., Wang, J., & Wang, Y. (2022) · Food & Function · doi:10.1039/d1fo03396d · Cited by 56
To rarefy or not to rarefy: robustness and efficiency trade-offs of rarefying microbiome data
Hong, J., Karaöz, U., de Valpine, P., & Fithian, W. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac127 · Cited by 57
A Review of the Recent Advances in Alzheimer’s Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics
Hajjo, R., Sabbah, D. A., Abusara, O. H., & Bawab, A. Q. A. (2022) · Diagnostics · doi:10.3390/diagnostics12122975 · Cited by 57
The association between gut microbiota and postoperative delirium in patients
Zhang, Y., Baldyga, K., Dong, Y., Song, W., Villanueva, M., Deng, H., Mueller, A., Houle, T. T., Marcantonio, E. R., & Xie, Z. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02450-1 · Cited by 56
Perioperative use of cefazolin ameliorates postoperative cognitive dysfunction but induces gut inflammation in mice
Liang, P., Shan, W., & Zuo, Z. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1274-6 · Cited by 56
Jatrorrhizine Balances the Gut Microbiota and Reverses Learning and Memory Deficits in APP/PS1 transgenic mice
Wang, S., Jiang, W., Ouyang, T., Shen, X., Wang, F., Qu, Y., Zhang, M., Luo, T., & Wang, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-56149-9 · Cited by 56
Diverse effects of different Akkermansia muciniphila genotypes on Brown adipose tissue inflammation and whitening in a high-fat-diet murine model
Deng, L., Ou, Z., Huang, D., Li, C., Lü, Z., Liu, W., Wu, F., Nong, C., Gao, J., & Peng, Y. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104353 · Cited by 56
Do the Bugs in Your Gut Eat Your Memories? Relationship between Gut Microbiota and Alzheimer’s Disease
Borsom, E. M., Lee, K., & Cope, E. K. (2020) · Brain Sciences · doi:10.3390/brainsci10110814 · Cited by 56
The Oral and Fecal Microbiota in a Canadian Cohort of Alzheimer’s Disease
Cirstea, M. S., Kliger, D., MacLellan, A. D., Yu, A. C., Langlois, J., Fan, M., Boroomand, S., Kharazyan, F., Hsiung, R. G. Y., MacVicar, B. A., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215520 · Cited by 56
Age-related metabolic and neurodegenerative changes in SAMP8 mice
Pačesová, A., Holubová, M., Hrubá, L., Strnadová, V., Neprašová, B., Pelantová, H., Kuzma, M., Železná, B., Kuneš, J., & Maletı́nská, L. (2022) · Aging · doi:10.18632/aging.204284 · Cited by 55
Gut microbiome characteristics in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease: a systematic review and meta‐analysis
Chen, G., Zhou, X., Zhu, Y., Shi, W., & Kong, L. (2023) · European Journal of Neurology · doi:10.1111/ene.15961 · Cited by 55
Systemic determinants of brain health in ageing
Smith, E. E., Biessels, G. J., Gao, V., Gottesman, R. F., Liesz, A., Parikh, N. S., & Iadecola, C. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01016-z · Cited by 57
Amyotrophic lateral sclerosis and intestinal microbiota—toward establishing cause and effect
Gotkine, M., Kviatcovsky, D., & Elinav, E. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1767464 · Cited by 55
Dynamic Changes in the Gut Microbiome at the Acute Stage of Ischemic Stroke in a Pig Model
Jeon, J. H., Lourenco, J. M., Kaiser, E. E., Waters, E. S., Scheulin, K. M., Fang, X., Kinder, H. A., Platt, S. R., Rothrock, M. J., Callaway, T. R., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.587986 · Cited by 55
Exploring the Potential Role of the Gut Microbiome in Chemotherapy-Induced Neurocognitive Disorders and Cardiovascular Toxicity
Čierniková, S., Mego, M., & Chovanec, M. (2021) · Cancers · doi:10.3390/cancers13040782 · Cited by 55
Functional roles of the microbiota-gut-brain axis in Alzheimer’s disease: Implications of gut microbiota-targeted therapy
Zhong, S.-R., Kuang, Q., Zhang, F., Chen, B., & Zhong, Z.-G. (2021) · Translational Neuroscience · doi:10.1515/tnsci-2020-0206 · Cited by 56
Evolutionary Significance of the Neuroendocrine Stress Axis on Vertebrate Immunity and the Influence of the Microbiome on Early-Life Stress Regulation and Health Outcomes
Ortega, V. A., Mercer, E. M., Giesbrecht, G. F., & Arrieta, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.634539 · Cited by 55
Elderly Patients with Mild Cognitive Impairment Exhibit Altered Gut Microbiota Profiles
Pan, Q., Li, Y., Guo, K., Xue, M., Gan, Y., Wang, K., Xu, D., & Tu, Q. (2021) · Journal of Immunology Research · doi:10.1155/2021/5578958 · Cited by 54
Neuroprotection of chicoric acid in a mouse model of Parkinson's disease involves gut microbiota and TLR4 signaling pathway
Wang, N., Feng, B., Hu, B., Cheng, Y., Guo, Y., & Qian, H. (2021) · Food & Function · doi:10.1039/d1fo02216d · Cited by 55
Gut- and oral-dysbiosis differentially impact spinal- and bulbar-onset ALS, predicting ALS severity and potentially determining the location of disease onset
Kim, H. S., Son, J. L., Lee, D., Tsai, J., Wang, D., Chocrón, E. S., Jeong, S., Kittrell, P., Murchison, C., Kennedy, R., et al. (2022) · BMC Neurology · doi:10.1186/s12883-022-02586-5 · Cited by 54
Gut Microbiota-Mediated Elevated Production of Secondary Bile Acids in Chronic Unpredictable Mild Stress
Qu, Y., Su, C., Zhao, Q., Shi, A., Zhao, F., Tang, L., Xu, D., Xiang, Z., Wang, Y., Wang, Y., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.837543 · Cited by 55
Hallmarks of neurodegenerative disease: A systems pharmacology perspective
Bloomingdale, P., Karelina, T., Ramakrishnan, V., Bakshi, S., Véronneau‐Veilleux, F., Moye, M., Sekiguchi, K., Meno‐Tetang, G. M. L., Mohan, A., Maithreye, R., et al. (2022) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12852 · Cited by 54
Fatty acids derived from the probiotic Lacticaseibacillus rhamnosus HA-114 suppress age-dependent neurodegeneration
Labarre, A., Guitard, E., Tossing, G., Forest, A., Bareke, E., Labrecque, M., Tétreault, M., Ruiz, M., & Parker, J. A. (2022) · Communications Biology · doi:10.1038/s42003-022-04295-8 · Cited by 55
Gut Microbiome and Modulation of CNS Function
Osadchiy, V., Martin, C. R., & Mayer, E. A. (2019) · Comprehensive Physiology · doi:10.1002/cphy.c180031 · Cited by 53
Photobiomodulation in experimental models of Alzheimer’s disease: state-of-the-art and translational perspectives
Huang, Z., Hamblin, M. R., & Zhang, Q. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01484-x · Cited by 54
The complex relationship between gut microbiota and Alzheimer’s disease: A systematic review
Zhou, X.-P., Sun, L.-B., Liu, W., Zhu, W.-M., Li, L.-C., Song, X., Xing, J.-P., & Gao, S. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102637 · Cited by 54
Molecular Tools to Detect Alloforms of Aβ and Tau: Implications for Multiplexing and Multimodal Diagnosis of Alzheimer’s Disease
Arora, H., Ramesh, M., Rajasekhar, K., & Govindaraju, T. (2020) · Bulletin of the Chemical Society of Japan · doi:10.1246/bcsj.20190356 · Cited by 53
The gut microbiome: implications for neurogenesis and neurological diseases
Zhou, F., Liu, C., Yang, S., & Wang, L. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.315227 · Cited by 52
Targeting gut microbiota to alleviate neuroinflammation in Alzheimer’s disease
Nguyen, V. T. T., & Endres, K. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114418 · Cited by 52

Authors: Vogt, N. M., Kerby, R. L., Dill-McFarland, K. A., Harding, S. J., Merluzzi, A. P., Johnson, S. C., Carlsson, C. M., Asthana, S., Zetterberg, H., Blennow, K., Bendlin, B. B., & Rey, F. E.
Affiliations: University of Wisconsin–Madison (US)
Sahlgrenska University Hospital (SE)
Corresponding author: Bendlin, Barbara B.
Rey, Federico E.
ORCID: Vogt, Nicholas M.
Kerby, Robert L.
Dill-McFarland, Kimberly A.
Johnson, Sterling C.
Carlsson, Cynthia M.
Asthana, Sanjay
Zetterberg, Henrik
Blennow, Kaj
Bendlin, Barbara B.
Rey, Federico E.
Venue: Scientific Reports
Publisher: Springer Science and Business Media LLC
Published: 2017-10-19
Volume: 7
Issue: 1
Pages: 13537-13537
ISSN: 2045-2322 (ISSN-L)
DOI: 10.1038/s41598-017-13601-y
PMC: PMC5648830
OpenAlex: W2761210275
Cited by: 2,137
References: 83
Citations by year: 2026: 205 · 2025: 322 · 2024: 328 · 2023: 269 · 2022: 339 · 2021: 283 · 2020: 205 · 2019: 119 · 2018: 64 · 2017: 1
FWCI: 43.23
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0 (tdm)
creativecommons.org/licenses/by/4.0 (vor)
Locations: Scientific Reports (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion, cc-by)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders: Alzheimer's Association (R01 AG027161, R01 AG037639, R01 AG021155)
Torsten Söderbergs Stiftelse
Rush University
Georgia Clinical and Translational Science Alliance (UL1TR000427)
Royal Swedish Academy of Sciences
Vetenskapsrådet
National Institutes of Health (UL1TR000427, NIH P50, AG027161, AG037639, NIH P50 AG033514, AG033514)
Institute for Clinical and Translational Research, University of Wisconsin, Madison (UL1TR000427)
National Institute on Aging (RF1AG027161, R01AG037639, P50AG033514, R01AG021155, R01AG027161, R56AG037639)
National Institute of General Medical Sciences (T32GM008692)
National Center for Advancing Translational Sciences
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Alzheimer's disease, gut microbiota, dementia, fecal microbiota, microbial diversity, Firmicutes, Bacteroidetes, Bifidobacterium, cerebrospinal fluid biomarkers, amyloid deposition, gut-brain axis, therapeutic target
MeSH terms: Bacillota, Gastrointestinal Microbiome, Aged, Alzheimer Disease, Bifidobacterium, Feces, Female, Humans, Male, Biomarkers, Case-Control Studies, tau Proteins, Bacteroidetes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Gut microbiome alterations in Alzheimer’s disease

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks